{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-055089","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.335276+00:00","generated_at":"2026-05-20T02:39:15.832723+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cognition Therapeutics files investor presentation on pathogenic oligomers approach","bullets":["Filed investor presentation dated June 2025 under Item 8.01.","Presentation focuses on targeting pathogenic oligomers for neurodegenerative diseases.","No financial, clinical, or operational updates provided in the filing.","Presentation may be used in discussions with investors and analysts."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-055089","json":"https://secwatch.observer/filing/0001104659-25-055089.json","markdown":"https://secwatch.observer/filing/0001104659-25-055089.md","text":"https://secwatch.observer/filing/0001104659-25-055089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925055089/0001104659-25-055089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925055089/tm2516681d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:39:15.832723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}